These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2562311)

  • 1. Immunologic response to influenza virus infection.
    Krystal M
    Immunol Ser; 1989; 43():597-621. PubMed ID: 2562311
    [No Abstract]   [Full Text] [Related]  

  • 2. Avian influenza virus infection of the immunosuppressed turkey.
    Robinson JH; Easterday BC
    Am J Vet Res; 1979 Sep; 40(9):1219-22. PubMed ID: 230771
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral and cell-mediated immune response to influenza virus. II. Experiments in ferrets.
    Semkow R; Loza-Tulimowska M; Brydak L; Zgorzelska K; Wilczyński J; Sadowski W
    Acta Microbiol Pol; 1982; 31(2):195-202. PubMed ID: 6188342
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of influenza A and B viruses. Use of monoclonal antibodies to analyze viruses from circumscribed epidemics.
    Oxford JS
    Prog Vet Microbiol Immunol; 1987; 3():214-34. PubMed ID: 2856221
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K
    Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.
    Beard CW; Easterday BC
    Avian Dis; 1973; 17(1):173-81. PubMed ID: 4697709
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural basis of immune recognition of influenza virus hemagglutinin.
    Wilson IA; Cox NJ
    Annu Rev Immunol; 1990; 8():737-71. PubMed ID: 2188678
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of cellular and humoral immunity to influenza virus in the guinea pig].
    Fehlmann HU; Gasser M; Jegge S
    Pathol Microbiol (Basel); 1974; 40(3):231-33. PubMed ID: 4843102
    [No Abstract]   [Full Text] [Related]  

  • 11. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
    McLain L; Dimmock NJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of morphological, biological and antigenic properties of avian influenza A virus haemagglutinin H2 in the course of adaptation to new host.
    Lipatov AS; Gitelman AK; Govorkova EA; Smirnov YuA
    Acta Virol; 1995 Dec; 39(5-6):279-81. PubMed ID: 8722298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on the immunizing and antigenic properties of some viral fractions extracted from influenza viruses of type A2].
    Moisa I; Lupu R; Blaer E
    Stud Cercet Virusol; 1972; 23(2):135-40. PubMed ID: 4646493
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE; Gordon MA; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
    Johansson BE; Moran TM; Bona CA; Popple SW; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2010-4. PubMed ID: 3624874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photometric method for determination of doubly specific influenza antibody.
    Drescher J; Masurel N
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):233-44. PubMed ID: 4150056
    [No Abstract]   [Full Text] [Related]  

  • 19. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus.
    Jackson DC; Drummer HE; Brown LE
    Virology; 1994 Feb; 198(2):613-23. PubMed ID: 7507281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.